Desloratadine


Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Allergic rhinitis, Urticaria
Adult: 5 mg once daily. Patients with intermittent allergic rhinitis must be managed according to the evaluation of disease history, treatment may be discontinued after the symptoms are resolved and reinitiated upon reappearance; in case of persistent allergic rhinitis, continuous treatment may be considered during the periods of allergen exposure. Treatment recommendations may vary among countries and individual products (refer to specific product guidelines).
Child: 1-5 years As oral solution or syrup: 1.25 mg once daily; 6-11 years As orodispersible tab, oral solution or syrup: 2.5 mg once daily; ≥12 years Same as adult dose. Treatment or dosage recommendations may vary among countries and individual products (refer to specific product guidelines).
Suy thận
Initially, 5 mg every other day. Dosage recommendations may vary among countries and individual products (refer to specific product guidelines).
Suy gan
Initially, 5 mg every other day. Dosage recommendations may vary among countries and individual products (refer to specific product guidelines).
Cách dùng
May be taken with or without food.
Thận trọng
Patients with medical or familial history of seizure disorders. Patients who are slow or poor metabolisers of desloratadine may have an increased risk of adverse effects. Renal and hepatic impairment. Children. Pregnancy and lactation.
Tác dụng không mong muốn
Significant: Increased risk of seizures (particularly in children). Very rarely, hypersensitivity reactions (e.g. anaphylaxis).
Gastrointestinal disorders: Dry mouth; diarrhoea (mainly in children <2 years).
General disorders and administration site conditions: Fatigue; fever (mainly in children <2 years).
Nervous system disorders: Headache.
Psychiatric disorders: Insomnia (mainly in children <2 years).
Respiratory, thoracic and mediastinal disorders: Pharyngitis; upper respiratory tract infection, cough (mainly in children <2 years).
Chỉ số theo dõi
Obtain renal function test and LFT at baseline. Monitor for signs and symptoms of hypersensitivity reactions.
Tương tác
May increase plasma concentrations with ketoconazole, erythromycin, azithromycin, fluoxetine, and cimetidine.
Ảnh hưởng đến kết quả xét nghiệm
May diminish the wheal and flare reactions to skin test antigens.
Tác dụng
Description:
Mechanism of Action: Desloratadine, the major active metabolite of loratadine, is a non-sedating, long-acting antihistamine. It selectively blocks peripheral histamine H1-receptors.
Onset: Within 1 hour.
Duration: 24 hours.
Pharmacokinetics:
Absorption: Well absorbed. Time to peak plasma concentration: Approx 3 hours.
Distribution: Enters breast milk. Volume of distribution: Approx 49 L/kg. Plasma protein binding: 82-87% (desloratadine); 85-89% (3-hydroxydesloratadine).
Metabolism: Extensively metabolised in the liver into the active metabolite, 3-hydroxydesloratadine, which undergoes further glucuronidation; enzyme(s) responsible for desloratadine metabolism is not yet identified. Decreased metabolism in slow metabolisers of desloratadine.
Excretion: Via urine (41%); faeces (47%). Elimination half-life: Approx 27 hours.
Đặc tính

Chemical Structure Image
Desloratadine

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 124087, Desloratadine. https://pubchem.ncbi.nlm.nih.gov/compound/Desloratadine. Accessed May 26, 2022.

Bảo quản
Store between 15-30°C. Storage recommendations may vary among countries or individual products. Refer to specific product guidelines.
Phân loại MIMS
Thuốc kháng histamin & kháng dị ứng
Phân loại ATC
R06AX27 - desloratadine ; Belongs to the class of other antihistamines for systemic use.
Tài liệu tham khảo
Aerius Syrup (Organon Malaysia Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 25/05/2022.

Aerius Tablets (Organon Malaysia Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 25/05/2022.

Ajalorin Orodispersible Tablet 2.5 mg and 5 mg (AJ Research & Pharma Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 07/04/2022.

Anon. Desloratadine. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 25/05/2022.

Anon. Desloratadine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 07/04/2022.

Avorius 5 mg Tablet (Apex Pharmacy Marketing Sdn Bhd). MIMS Malaysia. http://www.mims.com/malaysia. Accessed 07/04/2022.

Buckingham R (ed). Desloratadine. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 07/04/2022.

Desloratadine 2.5 mg Orodispersible Tablets (Bristol Laboratories Ltd). MHRA. https://products.mhra.gov.uk. Accessed 07/04/2022.

Desloratadine 5 mg Orodispersible Tablets (Bristol Laboratories Ltd). MHRA. https://products.mhra.gov.uk. Accessed 07/04/2022.

Desloratadine Tablet, Film Coated (Lupin Pharmaceuticals, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 07/04/2022.

Desloratadine Tablet, Orally Disintegrating (Dr. Reddy’s Laboratories Limited). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 07/04/2022.

Joint Formulary Committee. Desloratadine. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 07/04/2022.

Neoclarityn 0.5 mg/mL Oral Solution (Organon Pharma [UK] Limited). MHRA. https://products.mhra.gov.uk. Accessed 07/04/2022.

Neoclarityn 5 mg Film-coated Tablets (Organon Pharma [UK] Limited). MHRA. https://products.mhra.gov.uk. Accessed 07/04/2022.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Desloratadine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Celtalex
  • Dazit
  • Delopa
  • Delopedil
  • Des OD
  • Desloderma
  • Desloget
  • Deslora
  • Desloratadin Stada 5mg
  • Deslornine
  • Desnin
  • Dometin
  • Dozanavir
  • Elarothene 5mg
  • Eslorin-5
  • Eurodesa
  • Eurodora
  • Loriday
  • Pharmatadin
  • Ruradin
  • Sedno
  • Sketixe
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập